COMMUNIQUÉS West-GlobeNewswire
-
Dentsply Sirona Reports Third Quarter 2025 Results
06/11/2025 -
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
06/11/2025 -
Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
06/11/2025 -
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
06/11/2025 -
Healthcare Minus the Headache: RokketMed, A Solution to Finding the Care That Counts
06/11/2025 -
Raise Craze, a partnership between the MUHC Foundation, The Beat 92.5, and Pink in the City, raised $162,160 for breast cancer care at the MUHC
06/11/2025 -
La campagne Raise Craze, un partenariat entre la Fondation du CUSM, The Beat 92.5 et Pink in the City, recueille 162,160 $ pour les soins contre le cancer du sein au CUSM
06/11/2025 -
Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine
06/11/2025 -
Porch Light Health Launches Advanced Drug Lab to Improve Patient Safety and Spot Dangerous Drug Trends in Our Communities
06/11/2025 -
Pennant Group to Participate in the 2025 Stephens Annual Investment Conference
06/11/2025 -
PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering
06/11/2025 -
Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform
06/11/2025 -
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
06/11/2025 -
Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed
06/11/2025 -
Immunocore reports third quarter financial results and provides a business update
06/11/2025 -
ProQR Announces Third Quarter 2025 Operating and Financial Results
06/11/2025 -
TREOS Bio Announces Publication of Phase 1b Clinical Trial Results of PolyPEPI1018 Plus TAS-102 in Refractory MSS mCRC in JCO Oncology Advances
06/11/2025 -
American Shared Hospital Services Announces Third Quarter Financial Results Conference Call
06/11/2025 -
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
06/11/2025
Pages